WILEY MATTHEW T. (Chief Commercial Officer) sold 1.6% of their position (2.87K shares) of DEFINIUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $129.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/26/2026ACC: 0001193125-26-285558
Officer· Chief Commercial Officer
Since Feb 2026
-2.87K
Net shares
Net seller
$129.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.87K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−2.87K
Price / share
$45.03
Trade value
$129.10K
% of position
1.6%
6/25/2026
177.50K→174.63K
Total
Net shares
−2.87K
Net value
-$129.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/25/2026 | S · Sale | −2.87K | $45.03 | $129.10K | 1.6% | 177.50K | 174.63K |
| Total | −2.87K | -$129.10K | ||||||
Derivative Transactions0
No derivative transactions reported